Novel Antidepressant Reduces Depression Symptoms in 2 Weeks (NEJM Journal Watch, 2019--9-5)

https://www.jwatch.org/fw115787/2019/09/05/novel-antidepressant-reduces-depression-symptoms-2-weeks?query=pfwRSTOC&jwd=000013567342&jspc=P

SAGE-217, is an oral positive allosteric modulator of γ-aminobutyric acid (GABA) type A receptors